Literature DB >> 32661510

Metabolic Messengers: Adiponectin.

Leon G Straub1, Philipp E Scherer2.   

Abstract

Adiponectin is one of the most widely studied adipokines to date. First described in the mid-1990's, studying its regulation, biogenesis and physiological effects has proven to be extremely insightful and improved our understanding of the mechanisms that ensure systemic metabolic homeostasis. Here, we provide a brief overview of the current state of the field with respect to adiponectin, its history, sites and mechanisms of action, and the critical questions that will need to be addressed in the future.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 32661510      PMCID: PMC7357716          DOI: 10.1038/s42255-019-0041-z

Source DB:  PubMed          Journal:  Nat Metab        ISSN: 2522-5812


  91 in total

1.  The adipocyte-secreted protein Acrp30 enhances hepatic insulin action.

Authors:  A H Berg; T P Combs; X Du; M Brownlee; P E Scherer
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

Review 2.  Adiponectin, Leptin, and Fatty Acids in the Maintenance of Metabolic Homeostasis through Adipose Tissue Crosstalk.

Authors:  Jennifer H Stern; Joseph M Rutkowski; Philipp E Scherer
Journal:  Cell Metab       Date:  2016-05-10       Impact factor: 27.287

3.  Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Yoshihisa Okamoto; Shinji Kihara; Noriyuki Ouchi; Makoto Nishida; Yukio Arita; Masahiro Kumada; Koji Ohashi; Naohiko Sakai; Iichiro Shimomura; Hideki Kobayashi; Naoki Terasaka; Toshimori Inaba; Tohru Funahashi; Yuji Matsuzawa
Journal:  Circulation       Date:  2002-11-26       Impact factor: 29.690

4.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast.

Authors:  Kazuya Oshima; Akihide Nampei; Morihiro Matsuda; Masanori Iwaki; Atsunori Fukuhara; Jun Hashimoto; Hideki Yoshikawa; Iichiro Shimomura
Journal:  Biochem Biophys Res Commun       Date:  2005-06-03       Impact factor: 3.575

Review 5.  Adiponectin, driver or passenger on the road to insulin sensitivity?

Authors:  Risheng Ye; Philipp E Scherer
Journal:  Mol Metab       Date:  2013-04-19       Impact factor: 7.422

6.  Adiponectin acts in the brain to decrease body weight.

Authors:  Yong Qi; Nobuhiko Takahashi; Stanley M Hileman; Hiralben R Patel; Anders H Berg; Utpal B Pajvani; Philipp E Scherer; Rexford S Ahima
Journal:  Nat Med       Date:  2004-04-11       Impact factor: 53.440

7.  Adiponectin promotes functional recovery after podocyte ablation.

Authors:  Joseph M Rutkowski; Zhao V Wang; Ae Seo Deok Park; Jianning Zhang; Dihua Zhang; Ming Chang Hu; Orson W Moe; Katalin Susztak; Philipp E Scherer
Journal:  J Am Soc Nephrol       Date:  2013-01-18       Impact factor: 10.121

Review 8.  Adiponectin and cardiovascular inflammatory responses.

Authors:  Yukihiro Takemura; Kenneth Walsh; Noriyuki Ouchi
Journal:  Curr Atheroscler Rep       Date:  2007-09       Impact factor: 5.113

9.  The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity.

Authors:  T Yamauchi; J Kamon; H Waki; Y Terauchi; N Kubota; K Hara; Y Mori; T Ide; K Murakami; N Tsuboyama-Kasaoka; O Ezaki; Y Akanuma; O Gavrilova; C Vinson; M L Reitman; H Kagechika; K Shudo; M Yoda; Y Nakano; K Tobe; R Nagai; S Kimura; M Tomita; P Froguel; T Kadowaki
Journal:  Nat Med       Date:  2001-08       Impact factor: 53.440

10.  Systemic fate of the adipocyte-derived factor adiponectin.

Authors:  Nils Halberg; Todd D Schraw; Zhao V Wang; Ja-Young Kim; James Yi; Mark P Hamilton; Kate Luby-Phelps; Philipp E Scherer
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

View more
  33 in total

1.  Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation.

Authors:  Julian Schwärzler; Lisa Mayr; Susanne Kaser; Timon E Adolph; Bernhard Radlinger; Felix Grabherr; Maureen Philipp; Bernhard Texler; Christoph Grander; Andreas Ritsch; Monika Hunjadi; Barbara Enrich; Karin Salzmann; Qitao Ran; Lukas A Huber; Herbert Tilg
Journal:  Int J Obes (Lond)       Date:  2022-01-14       Impact factor: 5.095

Review 2.  Why does obesity cause diabetes?

Authors:  Samuel Klein; Amalia Gastaldelli; Hannele Yki-Järvinen; Philipp E Scherer
Journal:  Cell Metab       Date:  2022-01-04       Impact factor: 27.287

3.  Anti-depressive-like behaviors of APN KO mice involve Trkb/BDNF signaling related neuroinflammatory changes.

Authors:  Weifen Li; Tahir Ali; Chengyou Zheng; Kaiwu He; Zizhen Liu; Fawad Ali Shah; Ningning Li; Zhi-Jian Yu; Shupeng Li
Journal:  Mol Psychiatry       Date:  2021-10-12       Impact factor: 15.992

Review 4.  Contribution of specific ceramides to obesity-associated metabolic diseases.

Authors:  Philipp Hammerschmidt; Jens C Brüning
Journal:  Cell Mol Life Sci       Date:  2022-07-05       Impact factor: 9.207

5.  Pectin oligosaccharides improved lipid metabolism in white adipose tissue of high-fat diet fed mice.

Authors:  Zixin Fan; Xuejiao Chen; Tianzhi Liu; Qianhui Yu; Ziqi Song; Fei Wang; Tuoping Li
Journal:  Food Sci Biotechnol       Date:  2022-06-18       Impact factor: 3.231

Review 6.  The Lard Works in Mysterious Ways: Ceramides in Nutrition-Linked Chronic Disease.

Authors:  Rebekah J Nicholson; Marie K Norris; Annelise M Poss; William L Holland; Scott A Summers
Journal:  Annu Rev Nutr       Date:  2022-05-18       Impact factor: 9.323

Review 7.  Adiponectin, Leptin and Cardiovascular Disorders.

Authors:  Shangang Zhao; Christine M Kusminski; Philipp E Scherer
Journal:  Circ Res       Date:  2021-01-07       Impact factor: 17.367

Review 8.  The bifurcated role of adiponectin in colorectal cancer.

Authors:  Debrup Chakraborty; Wei Jin; Jing Wang
Journal:  Life Sci       Date:  2021-04-19       Impact factor: 6.780

Review 9.  Ceramides in Metabolism: Key Lipotoxic Players.

Authors:  Bhagirath Chaurasia; Scott A Summers
Journal:  Annu Rev Physiol       Date:  2020-11-06       Impact factor: 19.318

10.  Adipocyte iron levels impinge on a fat-gut crosstalk to regulate intestinal lipid absorption and mediate protection from obesity.

Authors:  Zhuzhen Zhang; Jan-Bernd Funcke; Zhenzhen Zi; Shangang Zhao; Leon G Straub; Yi Zhu; Qingzhang Zhu; Clair Crewe; Yu A An; Shiuhwei Chen; Na Li; May-Yun Wang; Alexandra L Ghaben; Charlotte Lee; Laurent Gautron; Luke J Engelking; Prithvi Raj; Yingfeng Deng; Ruth Gordillo; Christine M Kusminski; Philipp E Scherer
Journal:  Cell Metab       Date:  2021-06-25       Impact factor: 31.373

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.